Clinical Trial Update: MIBG With Dinutuximab +/- Vorinostat [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating MIBG with dinutuximab, with or without vorinostat, in neuroblastoma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• MIBG (metaiodobenzylguanidine)
• UNITUXIN (dinutuximab)
• Vorinostat (vorinostat)

Snippet

Sponsor: New Approaches to Neuroblastoma Therapy Consortium | Conditions: Neuroblastoma | Phase 1 | Status: COMPLETED | Results posted: 2025-04-16